Zacchaeus Anywaine
8PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 28, 2025
Counterfactual Groups to Assess Vaccine or Treatment Efficacy in HIV Prevention Trials in High-Risk Populations in Uganda.Andrew Abaasa, Yunia Mayanja, Zacchaeus Anywaine
|Aug 04, 2025
Rift Valley fever seroprevalence and risk factors among human populations in Uganda's cattle corridor: a cross-sectional study.Zacchaeus Anywaine, Daniel Wright, George M Warimwe
|Mar 25, 2022
Clinical manifestations of Rift Valley fever in humans: Systematic review and meta-analysis.Zacchaeus Anywaine, Swaib Abubaker Lule, Christian Hansen
|Jan 11, 2022
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial.Zacchaeus Anywaine, Houreratou Barry, Omu Anzala
|Oct 29, 2021
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.Houreratou Barry, Gaudensia Mutua, Hannah Kibuuka
|Mar 03, 2021
Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis.Jonathan Kitonsa, Julius Kiwanuka, Zacchaeus Anywaine
Pageof 2
Frequent Collaborators
2 joint publications
Jonathan Kitonsa
2 joint publications
Laura Richert
2 joint publications
Yunia Mayanja
2 joint publications
Julius Kiwanuka
2 joint publications
Kristen W Cohen
2 joint publications
M Juliana McElrath
2 joint publications
Jeremy Day
2 joint publications
Christine Lacabaratz
2 joint publications
Sodiomon B Sirima
2 joint publications
Houreratou Barry
